A large-scale study in Wales has provided the strongest evidence to date that the shingles vaccine may significantly lower the risk of developing Alzheimer's disease and other dementias. The research offers concrete data supporting the long-held theory that viral infections can influence dementia risk, marking a potential breakthrough in preventive neurology.
The landmark real-world analysis found that individuals who received the shingles shot were 20 percent less likely to develop dementia over a seven-year period compared to those who did not. This finding points to the vaccine, which targets the varicella-zoster virus, as a possible tool for reducing the burden of neurodegenerative disease. Researchers hope this evidence will spur further investigation into the mechanisms linking viral activity and brain health.
In other significant 2025 developments, a nonhormonal male birth control pill moved closer to reality after passing early-phase human safety trials. The daily oral contraceptive works by blocking a vitamin A metabolite in the testes, halting sperm production with effects that reverse when the medication is stopped. While larger trials are needed to confirm efficacy, the progress offers a future alternative to condoms and vasectomies.
Scientists also made strides in understanding popular GLP-1 drugs like Ozempic and Wegovy. New research explored why these medications alter food preferences for some users and revealed that the vast majority of people discontinue treatment within two years, raising questions about long-term health impacts after stopping. Concurrent genetics research is beginning to explain why a subset of "nonresponders" do not achieve significant weight loss.
From Supplements to Immune Discoveries
Amid a crowded market for wellness supplements, a review of the evidence identified three with notable anti-inflammatory effects: omega-3 fatty acids, curcumin, and vitamin D. Separately, an analysis suggested vitamin D might slow a marker of cellular aging, though experts caution this may not translate to clinical benefits. The year also saw hyperemesis gravidarum, a severe form of morning sickness, gain research traction as scientist Marlena Fejzo won a major prize for discovering key genes behind the condition.
Looking ahead, the scientific community is building on these discoveries. The Nobel Prize-winning work on regulatory T cells, the immune system's "peacekeepers," is fueling new approaches to treat autoimmune diseases and transplant complications. Furthermore, the urgent tracking of avian influenza across species underscores a continued focus on pandemic preparedness. Together, these advances highlight a year of meaningful progress, offering new tools for prevention, deeper understanding of existing treatments, and hope for managing some of medicine's most persistent challenges.